The Cost Of Change At Hoechst
Only last year, it seemed that Jurgen Dormann could do no wrong. The chief executive of German chemical and drug giant Hoechst saw his company's stock price soar 81% in 1996 as investors applauded his streamlining strategy. He was hailed as Mr. Shareholder Value--the man brave enough to lay off workers, exit weak businesses, and dump undervalued subsidiaries.
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.
- Uber Paid Hackers to Delete Stolen Data on 57 Million People
- European Stocks Drift as Dollar Extends Decline: Markets Wrap
- Tesla’s Burning Through Nearly Half a Million Dollars Every Hour
- Two Biggest Risks Now Are China and Inflation, Market Veteran Says
- What Analysts Are Saying About the Sudden Drop in Chinese Stocks